Persistence of Platelets Activation Prior to Second Doses of Covid-19 Vaccine After Vaccine-Induced Immune Thrombotic Thrombocytopenia

Clin Appl Thromb Hemost. 2022 Jan-Dec:28:10760296221086283. doi: 10.1177/10760296221086283.

Authors

Guillaume Roberge¹, Marc Carrier²

Affiliations

¹ Department of Medicine, 36896Centre Hospitalier Universitaire de Québec, Université Laval, Hôpital Saint-François d'Assise, Québec, Canada.
² Department of Medicine, 10055Ottawa Hospital Research Institute, University of Ottawa, Ontario, Canada.

No abstract available

Publication types

Letter

MeSH terms

Anticoagulants / administration & dosage
Anticoagulants / adverse effects
COVID-19* / immunology
COVID-19* / prevention & control
ChAdOx1 nCoV-19* / administration & dosage
ChAdOx1 nCoV-19* / adverse effects
ChAdOx1 nCoV-19* / immunology
Female
Humans
Male
Platelet Activation* / drug effects
Platelet Activation* / immunology
Purpura, Thrombotic Thrombocytopenic* / chemically induced
Purpura, Thrombotic Thrombocytopenic* / immunology
SARS-CoV-2 / immunology*

Substances

Anticoagulants
ChAdOx1 nCoV-19